Thrivent Financial for Lutherans’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $407K | Sell |
|
|||||
|
2025
Q2 | $649K | Hold |
|
|||||
|
2025
Q1 | $474K | Buy |
|
|||||
|
2024
Q4 | $254K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $98K | Sell |
|
|||||
|
2023
Q3 | $123K | Sell |
|
|||||
|
2023
Q2 | $1.08M | Buy |
|
|||||
|
2023
Q1 | $1.86M | Buy |
|
|||||
|
2022
Q4 | $930K | Sell |
|
|||||
|
2022
Q3 | $1.04M | Buy |
|
|||||
|
2022
Q2 | $856K | Buy |
|
|||||
|
2022
Q1 | $1.06M | Buy |
|
|||||
|
2021
Q4 | $1.09M | Buy |
|
|||||
|
2021
Q3 | $826K | Sell |
|
|||||
|
2021
Q2 | $647K | Sell |
|
|||||
|
2021
Q1 | $727K | Sell |
|
|||||
|
2020
Q4 | $623K | Sell |
|
|||||
|
2020
Q3 | $678K | Buy |
|
|||||
|
2020
Q2 | $681K | Buy |
|
|||||
|
2020
Q1 | $689K | Buy |
|
|||||
|
2019
Q4 | $786K | Sell |
|
|||||
|
2019
Q3 | $1.77M | Buy |
|
|||||
|
2019
Q2 | $1.05M | Buy |
|
|||||
|
2019
Q1 | $1.15M | Buy |
|
|||||
|
2018
Q4 | $786K | Buy |
|
|||||
|
2018
Q3 | $927K | Buy |
|
|||||
|
2018
Q2 | $1.15M | Buy |
|
|||||
|
2018
Q1 | $752K | Buy |
|
|||||
|
2017
Q4 | $523K | Buy |
|
|||||
|
2017
Q3 | $409K | Buy |
|
|||||
|
2017
Q2 | $303K | Buy |
|
|||||
|
2017
Q1 | $241K | Buy |
|
|||||
|
2016
Q4 | $250K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $1.32M | Buy |
|